Science
Tool could improve success in translating drugs from animal studies to humans – Medical Xpress
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn’s disease, end up becoming resistant or unresponsive to it.
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn’s disease, end up becoming resistant or unresponsive to it.
Scientists might be able to catch problems like this one earlier in the drug development process, when drugs move from testing in animals to clinical trials, with a new computational model developed by researchers from Purdue University and Massachusetts Institute of Technology.
The researchers call the model “TransComp-R.” In a study publi…
-
Noosa News14 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General12 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News14 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Business15 hours agoSolid superannuation gains continue to roll in